Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society International Consensus Statement
Open accessAbstract
This Consensus Statement from an international, multidisciplinary workshop sponsored by the Pituitary Society offers evidence-based graded consensus recommendations and key summary points for clinical practice on the diagnosis and management of prolactinomas. Epidemiology and pathogenesis, clinical presentation of disordered pituitary hormone secretion, assessment of hyperprolactinaemia and biochemical evaluation, optimal use of imaging strategies and disease-related complications are addressed. In-depth discussions present the latest evidence on treatment of prolactinoma, including efficacy, adverse effects and options for withdrawal of dopamine agonist therapy, as well as indications for surgery, preoperative medical therapy and radiation therapy. Management of prolactinoma in special situations is discussed, including cystic lesions, mixed growth hormone-secreting and prolactin-secreting adenomas and giant and aggressive prolactinomas. Furthermore, considerations for pregnancy and fertility are outlined, as well as management of prolactinomas in children and adolescents, patients with an underlying psychiatric disorder, postmenopausal women, transgender individuals and patients with chronic kidney disease. The workshop concluded that, although treatment resistance is rare, there is a need for additional therapeutic options to address clinical challenges in treating these patients and a need to facilitate international registries to enable risk stratification and optimization of therapeutic strategies.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328 · see citing works
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline
Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1692 · Cited by 1,844 · see citing works
Self-citationDiagnosis and Treatment of Pituitary Adenomas
Molitch, M. E. (2017) · JAMA · doi:10.1001/jama.2016.19699 · Cited by 1,016 · see citing works
Self-citationConsensus on diagnosis and management of Cushing's disease: a guideline update
Fleseriu, M., Auchus, R., Bancos, I., Ben-Shlomo, A., Bertherat, J., Biermasz, N. R., Boguszewski, C. L., Bronstein, M. D., Buchfelder, M., Carmichael, J. D., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00235-7 · Cited by 953 · see citing works
Self-citationHormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945 · cited 2× · see citing works
“As surgery and radiation can each induce hypopituitarism, the post-treatment evaluation timeline should be individualized 36 (see Supplementary Box 2 for further discussion).”
BackgroundSelf-citationGuidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Casanueva, F. F., Molitch, M. E., Schlechte, J., Abs, R., Bonert, V. S., Bronstein, M. D., Brue, T. C., Cappabianca, P., Colao, A., Fahlbusch, R., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02562.x · Cited by 824 · see citing works
Self-citationAdvances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. A. L. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 820 · see citing works
Self-citationAntipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634 · see citing works
Raverot, G., Burman, P., McCormack, A. I., Heaney, A. P., Petersenn, S., POPOVIC, V. M., Trouillas, J., Dekkers, O. M., & _, _. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0796 · Cited by 593 · see citing works
Self-citationClonal Origin of Pituitary Adenomas*
Herman-Bonert, V. S., Fagin, J. A., Gonsky, R., Kovács, K., & Melmed, S. K. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1427 · Cited by 556 · see citing works
Self-citationPituitary-Tumor Endocrinopathies.
Melmed, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810772 · Cited by 466 · see citing works
Self-citationMechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20401 · Cited by 458 · see citing works
Self-citationClinical Biology of the Pituitary Adenoma
Melmed, S. K., Kaiser, U. B., Lopes, M. B. S., Bertherat, J. Y., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A. M., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 342 · see citing works
Self-citationOn behalf of The Pituitary Society, E. G. O. P. T., Casanueva, F. F., Barkan, A. L., Buchfelder, M., Klibanski, A., Laws, E. R., Loeffler, J. S., Melmed, S. K., Mortini, P., Wass, J. A. H., et al. (2017) · Pituitary · doi:10.1007/s11102-017-0838-2 · Cited by 315 · see citing works
Self-citationSwiglo, B. A., Murad, M. H., Schünemann, H. J., Kunz, R., Vigersky, R. A., Guyatt, G. H., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1907 · Cited by 302 · see citing works
Sex-Related Difference in the Growth of Prolactinomas: A Clinical and Proliferation Marker Study1
Delgrange, E., Trouillas, J., Maiter, D. M., Donckier, J. E., & TOURNIAIRE, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4088 · Cited by 300 · see citing works
Self-citationMcCormack, A. I., Dekkers, O. M., Petersenn, S., POPOVIC, V. M., Trouillas, J., Raverot, G., Burman, P., _, _., _, _., Hubalewska-Dydejezky, A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0933 · Cited by 286 · see citing works
Self-citationAcromegaly: pathogenesis, diagnosis, and management
Fleseriu, M., Langlois, F., Lim, D. S. T., Varlamov, E. V., & Melmed, S. K. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00244-3 · Cited by 285 · see citing works
Self-citationThe Natural History of Untreated Hyperprolactinemia: A Prospective Analysis*
Schlechte, J., Dolan, K. D., Sherman, B. M., Chapler, F. K., & Luciano, A. A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-412 · Cited by 269 · see citing works
Colao, A., Sarno, A., Cappabianca, P., Briganti, F., Pivonello, R., Somma, C. D., Faggiano, A., Biondi, B., & Lombardi, G. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480325 · Cited by 267 · see citing works
Self-citationHyperprolactinemia and Prolactinomas
Mancini, T., Casanueva, F. F., & Giustina, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.013 · Cited by 257 · see citing works
Self-citationColao, A., Vitale, G., Cappabianca, P., Briganti, F., Ciccarelli, A., De Rosa, M., Zarrilli, S., & Lombardi, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030979 · Cited by 256 · see citing works
The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new
Chanson, P., & Maiter, D. M. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101290 · Cited by 237 · see citing works
Self-citationKaravitaki, N., Thanabalasingham, G., Shore, H. C. A., Trifanescu, R. A., Ansorge, O., Meston, N., Turner, H. E., & Wass, J. A. H. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02627.x · Cited by 231 · see citing works
Self-citationQuality of Life in Patients with a Pituitary Adenoma
Johnson, M. D., Woodburn, C. J., & Vance, M. L. (2003) · Pituitary · doi:10.1023/b:pitu.0000004798.27230.ed · Cited by 231 · see citing works
Multiple Endocrine Neoplasia Type 1: Latest Insights
Brandi, M. L., Agarwal, S. K., Perrier, N. D., Lines, K. E., Valk, G. D., & Thakker, R. V. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa031 · Cited by 223 · see citing works
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients
Vroonen, L., Jaffrain‐Rea, M., Pétrossians, P., Tamagno, G., Chanson, P., Vilar, L., Borson‐Chazot, F., Naves, L. A., Brue, T. C., Gatta‐Cherifi, B., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0236 · Cited by 205 · see citing works
Self-citationKreutzer, J., Buslei, R., Wallaschofski, H., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0248 · Cited by 201 · see citing works
THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas
Maiter, D. M., & Delgrange, E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0013 · Cited by 199 · see citing works
Self-citationHyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration
Sonigo, C., Bouilly, J., Carré, N., Tolle, V., Caraty, A., Tello, J., Simony-Conesa, F.-J., Millar, R., Young, J., & Binart, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63937 · Cited by 197 · see citing works
Aggressive pituitary tumours and pituitary carcinomas
Raverot, G., Ilie, M. D., Lasolle, H., Amodru, V., Trouillas, J., Castinetti, F., & Brue, T. C. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00550-w · Cited by 191 · see citing works
Self-citationSurgical Treatment of Prolactin-Secreting Pituitary Adenomas: Early Results and Long-Term Outcome
Losa, M., Mortini, P., Barzaghi, L. R., Gioia, L., & Giovanelli, M. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8645 · Cited by 182 · see citing works
Management of Dopamine Agonist-Resistant Prolactinoma
Maiter, D. M. (2018) · Neuroendocrinology · doi:10.1159/000495775 · Cited by 181 · see citing works
Self-citationOlukoga, & Kane (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00757.x · Cited by 174 · see citing works
ENDOCRINOLOGY IN PREGNANCY: Management of the pregnant patient with a prolactinoma
Molitch, M. E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0848 · Cited by 169 · see citing works
Self-citationPrimeau, V., Raftopoulos, C., & Maiter, D. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1000 · Cited by 166 · see citing works
Self-citationPrimary Medical Therapy of Micro- and Macroprolactinomas in Men
Pinzone, J. J., Katznelson, L. J., Danila, D. C., Ankerst, D. P., Miller, C. S., & Klibanski, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6798 · Cited by 162 · see citing works
Self-citationMolitch, M. E. (2008) · Pituitary · doi:10.1007/s11102-008-0106-6 · Cited by 160 · see citing works
Self-citationBurnett-Bowie, S.-A. M., McKay, E. A., Lee, H., & Leder, B. Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0739 · Cited by 146 · see citing works
Najafabadi, A. H. Z., Zandbergen, I. M., de Vries, F., Broersen, L. H. A., Marle, M. E. V. D. A., Pereira, A. M., Peul, W. C., Dekkers, O. M., van Furth, W. R., & Biermasz, N. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz144 · Cited by 145 · see citing works
Self-citationLasolle, H., Cortet, C., Castinetti, F., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0979 · Cited by 143 · see citing works
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139 · see citing works
Self-citationTemozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
Losa, M., Bogazzi, F., Cannavò, S., Ceccato, F., Curtò, L., Marinis, L. D., Iacovazzo, D., Lombardi, G., Mantovani, G., Mazza, E. A., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1991-y · Cited by 136 · see citing works
Diagnosis of Primary Hypophysitis in Germany
Honegger, J. B., Schlaffer, S. M., Menzel, C., Droste, M., Werner, S., Elbelt, U., Strasburger, C. J., Störmann, S., Küppers, A., der Werf, C. S.-V., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2152 · Cited by 126 · see citing works
Self-citationProlactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues.
Saleem, M., Martin, H., & Coates, P. S. (2018) · Europe PMC (PubMed Central) · Cited by 125 · see citing works
Hou, S., Grossman, S. D., & Molitch, M. E. (1985) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(85)80181-5 · Cited by 123 · see citing works
Self-citationSamperi, I., Lithgow, K. C., & Karavitaki, N. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122203 · Cited by 119 · see citing works
Self-citationRecurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy
Kharlip, J., Salvatori, R., Yenokyan, G., & Wand, G. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2103 · Cited by 118 · see citing works
Self-citationGiant prolactinomas: the therapeutic approach
Moraes, A. B., Silva, C. M. D. S., Neto, L. V., & Gadelha, M. R. (2013) · Clinical Endocrinology · doi:10.1111/cen.12242 · Cited by 116 · see citing works
Self-citationAggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
Burman, P., Burman, P., Trouillas, J., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0440 · Cited by 111 · see citing works
Vertebral fractures in males with prolactinoma
Mazziotti, G., Porcelli, T., Mormando, M., De Menis, E., Bianchi, A., Mejia, C., Mancini, T., De Marinis, L., & Giustina, A. (2011) · Endocrine · doi:10.1007/s12020-011-9462-5 · Cited by 109 · see citing works
Self-citationSalenave, S., Ancelle, D., Bahougne, T., Raverot, G., Kamenický, P., Bouligand, J., Guiochon‐Mantel, A., Linglart, A., Souchon, P., Nicolino, M. P., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3670 · Cited by 108 · see citing works
Self-citationThe effect of the menopause on prolactin levels in patients with hyperprolactinaemia
Karunakaran, S., Page, R. C., & Wass, J. A. H. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01190.x · Cited by 104 · see citing works
Self-citationESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy
Luger, A., Broersen, L. H. A., Biermasz, N. R., Biller, B. M. K., Buchfelder, M., Chanson, P., Jørgensen, J. O. L., Keleştimur, F., Llahana, S., Maiter, D. M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0462 · Cited by 104 · see citing works
Self-citationEffect of dopaminergic drug treatment on surgical findings in prolactinomas
Menucci, M., Quiñones‐Hinojosa, A., Burger, P. C., et al. (2010) · Pituitary · doi:10.1007/s11102-010-0261-4 · Cited by 101 · see citing works
PCOS and Hyperprolactinemia: what do we know in 2019?
Delcour, C., Robin, G., Young, J., & Dewailly, D. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119871921 · Cited by 101 · see citing works
Mazziotti, G., Mancini, T., Mormando, M., De Menis, E., Bianchi, A., Doga, M., Porcelli, T., Vescovi, P. P., De Marinis, L., & Giustina, A. (2011) · Pituitary · doi:10.1007/s11102-011-0293-4 · Cited by 98 · see citing works
Self-citationProlactin and autoimmunity: The hormone as an inflammatory cytokine
Borba, V. V., Zandman‐Goddard, G., & Shoenfeld, Y. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101324 · Cited by 94 · see citing works
Somatic SF3B1 hotspot mutation in prolactinomas
Li, C., Xie, W., Rosenblum, J. S., Zhou, J., Guo, J., Miao, Y., Shen, Y., Wang, H., Gong, L., Li, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16052-8 · Cited by 89 · see citing works
Lam, G., Mehta, V., & Zada, G. (2012) · Neurosurgical FOCUS · doi:10.3171/2012.4.focus1268 · Cited by 88 · see citing works
Tampourlou, M., Trifanescu, R. A., Paluzzi, A., Ahmed, S. K., & Karavitaki, N. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0087 · Cited by 88 · see citing works
Self-citationIoachimescu, A. G., Fleseriu, M., Hoffman, A. R., Vaughan, T. B., & Katznelson, L. J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0682 · Cited by 88 · see citing works
Self-citationSousa, S. M. C. D., Baranoff, J. A., Rushworth, R. L., Butler, J., Sorbello, J., Vorster, J., Thompson, T. J., McCormack, A. I., Inder, W. J., & Torpy, D. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz076 · Cited by 87 · see citing works
Self-citationHYPERPROLACTINAEMIA IN RENAL DISEASE
Cowden, E. A., RATCLIFFE, W. A., Ratcliffe, J. G., et al. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb02206.x · Cited by 85 · see citing works
Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas
Zhang, D., Way, J. S. A., Zhang, X., Mareninov, S., Bergsneider, M., Wang, M. B., Yong, W. H., & Heaney, A. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02461 · Cited by 84 · see citing works
Pituitary adenomas: possible role of bromocriptine in intratumoral hemorrhage.
Yousem, D. M., Arrington, J. A., Zinreich, S. J., et al. (1989) · Radiology · doi:10.1148/radiology.170.1.2909102 · Cited by 79 · see citing works
Modern imaging of pituitary adenomas
Bashari, W. A., Senanayake, R., Fernández‐Pombo, A., et al. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.05.002 · Cited by 76 · see citing works
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas
Cooper, O. B., Bonert, V. S., Rudnick, J. D., Pressman, B. D., Lo, J., Salvatori, R., Yuen, K. C. J., Fleseriu, M., & Melmed, S. K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa805 · Cited by 72 · see citing works
Self-citationTransient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment
Defreyne, J., Nota, N. M., Pereira, C., Schreiner, T., Fisher, A. D., den Heijer, M., & T'Sjoen, G. G. (2017) · LGBT Health · doi:10.1089/lgbt.2016.0190 · Cited by 70 · see citing works
Transsphenoidal microsurgical results of female patients with prolactinomas
Ikeda, H., Watanabe, K., Tominaga, T., & Yoshimoto, T. (2013) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.02.016 · Cited by 69 · see citing works
Zhu, Y., Zhang, C., Siafis, S., Zhuo, K., Zhu, D., Wu, H., Liu, D., Jiang, K., Wang, J., Leucht, S., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.08.013 · Cited by 69 · see citing works
Surgery for prolactinomas: a better choice?
Honegger, J. B., Nasi‐Kordhishti, I., Aboutaha, N., et al. (2019) · Pituitary · doi:10.1007/s11102-019-01016-z · Cited by 67 · see citing works
Self-citationXia, M. Y., Lou, X., Lin, S., & Wu, Z. B. (2017) · Endocrine · doi:10.1007/s12020-017-1444-9 · Cited by 65 · see citing works
Neuroendocrine alterations in the somatotropic and lactotropic axes in uremic men
Veldhuis, J. D., Iranmanesh, A., Wilkowski, M. J., et al. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1310489 · Cited by 64 · see citing works
Shimon, I. (2018) · Neuroendocrinology · doi:10.1159/000495184 · Cited by 62 · see citing works
Self-citationTestosterone-Related Exacerbation of a Prolactin-Producing Macroadenoma: Possible Role for Estrogen
Prior, J. C., Cox, T.-A., FAIRHOLM, D., Kostashuk, E. C., & NUGENT, R. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-2-391 · Cited by 61 · see citing works
Stiles, C. E., Tetteh-Wayoe, E. T., Bestwick, J. P., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01071 · Cited by 60 · see citing works
Cabergoline-induced psychotic exacerbation in schizophrenic patients
Chang, S.-C., Chen, C.-H., & Lu, M. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.11.002 · Cited by 59 · see citing works
Prolactinomas in males: any differences?
Duskin‐Bitan, H., & Shimon, I. (2019) · Pituitary · doi:10.1007/s11102-019-01009-y · Cited by 59 · see citing works
Self-citationdi Filippo, L., Doga, M., Resmini, E., & Giustina, A. (2020) · Pituitary · doi:10.1007/s11102-020-01041-3 · Cited by 59 · see citing works
Self-citationElbelt, U., Schlaffer, S. M., Buchfelder, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz211 · Cited by 58 · see citing works
Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis
Hoffmann, A., Adelmann, S., Lohle, K., Claviez, A., & Muller, H. L. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-3042-5 · Cited by 56 · see citing works
Growth potential of prolactinomas in men: is it really different from women?
Nishioka, H., Haraoka, J., & Akada, K. (2003) · Surgical Neurology · doi:10.1016/s0090-3019(03)00012-0 · Cited by 55 · see citing works
Nota, N. M., Dekker, M. J. H. J., Klaver, M., Wiepjes, C. M., van Trotsenburg, M., Heijboer, A. C., & den Heijer, M. (2016) · Andrologia · doi:10.1111/and.12666 · Cited by 55 · see citing works
Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes
Santharam, S., Tampourlou, M., Arlt, W., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13399 · Cited by 55 · see citing works
Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study
Soto‐Pedre, E., Newey, P. J., Bevan, J. S., & Leese, G. (2017) · Endocrine Connections · doi:10.1530/ec-17-0171 · Cited by 55 · see citing works
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
Ilie, M. D., Villa, C., Cuny, T., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0647 · Cited by 55 · see citing works
Dopamine Agonists Can Reduce Cystic Prolactinomas
Faje, A. T., Chunharojrith, P., Nency, J., Biller, B. M. K., Swearingen, B., & Klibanski, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2008 · Cited by 53 · see citing works
Self-citationWallace, I. R., Satti, N., Courtney, C. H., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0114 · Cited by 52 · see citing works
Male acquired hypogonadotropic hypogonadism: Diagnosis and treatment
Salenave, S., Trabado, S., Maione, L., Brailly‐Tabard, S., & Young, J. (2012) · Annales d Endocrinologie · doi:10.1016/j.ando.2012.03.040 · Cited by 51 · see citing works
Gender-related differences in prolactinomas. A clinicopathological study.
Schaller, B. J. (2005) · PubMed · Cited by 51 · see citing works
Doğanşen, S. Ç., Yalın, G. Y., Tanrıkulu, S., Tekin, S., Nizam, N., Bılgıç, B., Sencer, S., & Yarman, S. (2018) · Pituitary · doi:10.1007/s11102-018-0877-3 · Cited by 51 · see citing works
Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery
Zieliński, G., Ozdarski, M., Maksymowicz, M., Szamotulska, K., & Witek, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00439 · Cited by 51 · see citing works
Women with prolactinomas presented at the postmenopausal period
Shimon, I., Bronstein, M. D., Shapiro, J., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0259-1 · Cited by 50 · see citing works
Self-citationHyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years
Shimon, I., Hirsch, D., Tsvetov, G., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01962-5 · Cited by 50 · see citing works
Self-citationMechanisms of Central Hypogonadism
Barber, T. M., Kyrou, I., Kaltsas, G., Grossman, A. B., Randeva, H. S., & Weickert, M. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158217 · Cited by 50 · see citing works
Hypopituitarism patterns and prevalence among men with macroprolactinomas
Tirosh, A., Benbassat, C. A., Lifshitz, A., et al. (2014) · Pituitary · doi:10.1007/s11102-014-0563-z · Cited by 49 · see citing works
Baussart, B., Villa, C., Jouinot, A., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0293 · Cited by 49 · see citing works
Wan, X., Chen, J., Wang, J., et al. (2022) · Current Medical Science · doi:10.1007/s11596-022-2673-6 · Cited by 49 · see citing works
Hyperprolactinemia in End-Stage Renal Disease and Effects of Frequent Hemodialysis
Lo, J. C., Beck, G. J., Kaysen, G., Chan, C. T., Kliger, A., Rocco, M. V., & Chertow, G. M. (2016) · Hemodialysis international. International Symposium on Home Hemodialysis · doi:10.1111/hdi.12489 · Cited by 47 · see citing works
Cabergoline Tapering Is Almost Always Successful in Patients With Macroprolactinomas
Paepegaey, A. C., Salenave, S., Kamenický, P., Maione, L., Brailly‐Tabard, S., Young, J., & Chanson, P. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00038 · Cited by 47 · see citing works
Self-citationRibeiro, R. S., & Abucham, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0084 · Cited by 46 · see citing works
Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal
Santharam, S., Fountas, A., Tampourlou, M., Arlt, W., Ayuk, J., Gittoes, N. J. L., Toogood, A. A., & Karavitaki, N. (2018) · Clinical Endocrinology · doi:10.1111/cen.13765 · Cited by 46 · see citing works
Self-citationProlactinomas in pregnancy: considerations before conception and during pregnancy
Glezer, A., & Bronstein, M. D. (2019) · Pituitary · doi:10.1007/s11102-019-01010-5 · Cited by 45 · see citing works
Self-citationMa, Q., Su, J., Li, Y., Wang, J., Long, W., Luo, M., & Liu, Q. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00636 · Cited by 43 · see citing works
Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
Lee, Y., Ku, C. R., Kim, E. H., Hong, J. W., Lee, E. J., & Kim, S. H. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.280 · Cited by 42 · see citing works
Burke, W. T., Penn, D. L., Castlen, J. P., Donoho, D. A., Repetti, C. S., Iuliano, S., Barkhoudarian, G., & Laws, E. R. (2019) · Journal of neurosurgery · doi:10.3171/2019.3.jns19121 · Cited by 42 · see citing works
Pituitary Tumor Apoplexy in Adolescents
Jankowski, P. P., Crawford, J. R., Khanna, P. C., et al. (2014) · World Neurosurgery · doi:10.1016/j.wneu.2014.12.026 · Cited by 41 · see citing works
Importance of cannulated prolactin test in the definition of hyperprolactinaemia
Whyte, M., Pramodh, S., Srikugan, L., Gilbert, J. A., MIELL, J. P., Sherwood, R. A., McGregor, A., & Aylwin, S. J. B. (2014) · Pituitary · doi:10.1007/s11102-014-0576-7 · Cited by 40 · see citing works
Kreutz, J., Vroonen, L., Cattin, F., et al. (2015) · Neuroradiology · doi:10.1007/s00234-015-1519-3 · Cited by 40 · see citing works
Magnetic resonance imaging in the management of prolactinomas; a review of the evidence
Varlamov, E. V., Hinojosa‐Amaya, J. M., & Fleseriu, M. (2019) · Pituitary · doi:10.1007/s11102-019-01001-6 · Cited by 40 · see citing works
Self-citationAnna, B., Musolino, N. R. D. C., Gadelha, M. R., Marques, C., de Castro, M., Elias, P. C. L., Vilar, L., Lyra, R., Martins, M. R. A., Quidute, A. R. P., et al. (2019) · Pituitary · doi:10.1007/s11102-019-01008-z · Cited by 40 · see citing works
Self-citationSexual Dysfunction Associated with Hyperprolactinemia in Males and Females Undergoing Hemodialysis
Weizman, R., Weizman, A., Levi, J., et al. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198306000-00008 · Cited by 39 · see citing works
Burlacu, M., Maiter, D. M., Duprez, T. P. J., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1765-3 · Cited by 39 · see citing works
Self-citationThe Role of Surgery in the Management of Prolactinomas
Donoho, D. A., & Laws, E. R. (2019) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2019.05.010 · Cited by 39 · see citing works
Aggressive prolactinomas: how to manage?
Lasolle, H., Ilie, M. D., & Raverot, G. (2019) · Pituitary · doi:10.1007/s11102-019-01000-7 · Cited by 39 · see citing works
Self-citationAggressive pituitary tumors in the young and elderly
Tatsi, C., & Stratakis, C. A. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09534-8 · Cited by 39 · see citing works
The Role of Dopamine Agonists in Pituitary Adenomas
Giraldi, E. A., & Ioachimescu, A. G. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.05.006 · Cited by 38 · see citing works
Self-citationHinojosa‐Amaya, J. M., Johnson, N., Gonzalez‐Torres, C., Varlamov, E. V., Yedinak, C. G., McCartney, S., & Fleseriu, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.579606 · Cited by 38 · see citing works
Self-citationMicko, A. S. G., Vila, G., Höftberger, R., Knosp, E., & Wolfsberger, S. (2018) · Neurosurgery · doi:10.1093/neuros/nyy385 · Cited by 37 · see citing works
Self-citationEroukhmanoff, J., Téjédor, I., Potorac, I., Cuny, T., Bonneville, J., Dufour, H., Weryha, G., Beckers, A. M., Touraine, P. A., Brue, T. C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0897 · Cited by 36 · see citing works
Outcomes of Transsphenoidal Microsurgery for Prolactinomas – A Contemporary Series of 162 Cases
Giese, S., Nasi‐Kordhishti, I., & Honegger, J. B. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1247-4908 · Cited by 36 · see citing works
Self-citationDay, P., Glerean, M., Lovazzano, S., et al. (2010) · Frontiers of hormone research · doi:10.1159/000318494 · Cited by 35 · see citing works
Second attempt to withdraw cabergoline in prolactinomas: a pilot study
Kwancharoen, R., Auriemma, R. S., Yenokyan, G., Wand, G. S., Colao, A. A. L., & Salvatori, R. (2013) · Pituitary · doi:10.1007/s11102-013-0525-x · Cited by 35 · see citing works
Self-citationOvergaard, M., & Pedersen, S. M. (2017) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0902 · Cited by 35 · see citing works
Nachtigall, L. B., Karavitaki, N., Kiseljak‐Vassiliades, K., et al. (2018) · Pituitary · doi:10.1007/s11102-018-0924-0 · Cited by 35 · see citing works
Self-citationSurgery for Prolactinomas to Date
Buchfelder, M., Zhao, Y., & Schlaffer, S.-M. (2019) · Neuroendocrinology · doi:10.1159/000497331 · Cited by 35 · see citing works
Steeds, R. P., Stiles, C. E., Sharma, V., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.13940 · Cited by 35 · see citing works
Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study
Bras, M. L., Leclerc, H., Rousseau, O., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0630 · Cited by 35 · see citing works
Prolactin immunoassay: does the high-dose hook effect still exist?
Raverot, V., Perrin, P., Chanson, P., Jouanneau, E., Brue, T. C., & Raverot, G. (2022) · Pituitary · doi:10.1007/s11102-022-01246-8 · Cited by 35 · see citing works
Self-citationAlosaimi, F. D., Fallata, E. O., Abalhassan, M. F., Alhabbad, A. A., Alzain, N. M., Alhaddad, B., & Alassiry, M. Z. (2018) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2018.1425459 · Cited by 34 · see citing works
Perić, B., Kruljac, I., Šundalić, S., et al. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1135444 · Cited by 32 · see citing works
Goichot, B., Taquet, M., Baltzinger, P., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14645 · Cited by 32 · see citing works
Tirosh, A., Benbassat, C. A., & Shimon, I. (2015) · Endocrine Practice · doi:10.4158/ep15804.or · Cited by 31 · see citing works
Self-citationBreil, T., Lorz, C., Choukair, D., Mittnacht, J., Inta, I. M., Klose, D., Jesser, J., Schulze, E., & Bettendorf, M. (2018) · Hormone Research in Paediatrics · doi:10.1159/000486280 · Cited by 31 · see citing works
Dopamine agonists in prolactinomas: when to withdraw?
Souteiro, P., Belo, S., & Carvalho, D. M. (2019) · Pituitary · doi:10.1007/s11102-019-00989-1 · Cited by 31 · see citing works
Sehemby, M., Lila, A. R., Sarathi, V., Shah, R., Sankhe, S., Jaiswal, S. K., Ramteke‐Jadhav, S., Patil, V. A., Shah, N. S., & Bandgar, T. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa650 · Cited by 31 · see citing works
Determinants of Surgical Remission in Prolactinomas: A Systematic Review and Meta-Analysis
Wright, K. E., Chaker, L., Pacione, D. R., Sam, K. T., Feelders, R. A., Xia, Y., & Agrawal, N. (2021) · World Neurosurgery · doi:10.1016/j.wneu.2021.07.035 · Cited by 31 · see citing works
Hyperprolactinemia due to spontaneous intracranial hypotension
Schievink, W. I., Nuño, M., Rozen, T. D., et al. (2014) · Journal of neurosurgery · doi:10.3171/2014.9.jns132687 · Cited by 30 · see citing works
Shimon, I., Benbassat, C. A., Tzvetov, G., & Grozinsky‐Glasberg, S. (2010) · Pituitary · doi:10.1007/s11102-010-0251-6 · Cited by 30 · see citing works
Self-citationGallo‐Bernal, S., Patino-Jaramillo, N. G., Calixto, C. A., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12081816 · Cited by 30 · see citing works
Giant Prolactinoma in Men: Clinical Features and Therapeutic Outcomes
Iglesias, P., Arcano, K., Berrocal, V. R., et al. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0752-0741 · Cited by 29 · see citing works
Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas
de la Piscina, I. M., Najera, N. P., Rica, I., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0075 · Cited by 29 · see citing works
Dekkers, O. M., Ehrenstein, V., Bengtsen, M. B., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0282 · Cited by 28 · see citing works
Prolactinomas and menopause: any changes in management?
Greenman, Y. (2019) · Pituitary · doi:10.1007/s11102-019-00998-0 · Cited by 27 · see citing works
Self-citationImmunotherapy in pituitary carcinomas and aggressive pituitary tumors
Raverot, G., & Ilie, M. D. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101712 · Cited by 27 · see citing works
Self-citationManagement of cystic prolactinomas: a review
Nakhleh, A., Shehadeh, N., Hochberg, I., Zloczower, M., Zolotov, S., Taher, R., & Naccache, D. D. (2018) · Pituitary · doi:10.1007/s11102-018-0888-0 · Cited by 26 · see citing works
Biochemical diagnosis in prolactinomas: some caveats
Petersenn, S. (2019) · Pituitary · doi:10.1007/s11102-019-01024-z · Cited by 26 · see citing works
Self-citationSurgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis
Yagnik, K. J., Erickson, D. Z., Bancos, I., Atkinson, J. L. D., Choby, G. W., Peris‐Celda, M., & Gompel, J. J. V. (2021) · Pituitary · doi:10.1007/s11102-021-01188-7 · Cited by 26 · see citing works
Bakker, L. E. H., Verstegen, M. J. T., Ghariq, E., Verbist, B. M., Schutte, P. J., Bashari, W. A., Kruit, M. C., Pereira, A. M., Gurnell, M., Biermasz, N. R., et al. (2022) · Pituitary · doi:10.1007/s11102-022-01230-2 · Cited by 26 · see citing works
Self-citationVilar, L., Albuquerque, J. L., Gadelha, P. S., Filho, F. R., Siqueira, A. M. C., da Fonseca, M. M., Viana, K. F., Gomes, B. S., & Lyra, R. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00011 · Cited by 25 · see citing works
Abou‐Al‐Shaar, H., Mallela, A. N., Patel, A., et al. (2022) · Pituitary · doi:10.1007/s11102-022-01221-3 · Cited by 25 · see citing works
Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin
Schaefer, R. M., Kokot, F., Kuerner, B., et al. (1989) · The International Journal of Artificial Organs · doi:10.1177/039139888901200707 · Cited by 24 · see citing works
Huang, H. Y., Lin, S., Zhao, W. G., et al. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0217-3 · Cited by 24 · see citing works
Predictors of the Response to Dopaminergic Therapy in Patients With Prolactinoma
Hage, C., & Salvatori, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa652 · Cited by 24 · see citing works
Self-citationRadiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure
Akinduro, O. O., Lu, V. M., Izzo, A., Biase, G. D., Vilanilam, G. K., Gompel, J. J. V., Bernet, V. J., Donaldson, A. M., Olomu, O. U., Meyer, F. B., et al. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.05.249 · Cited by 23 · see citing works
Force, B. K., Staggers, K. A., Sebastian, S., Takashima, M., Yoshor, D., & Samson, S. L. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.10.043 · Cited by 23 · see citing works
Self-citationBalint‐Peric, L., & Prelević, G. M. (1997) · Gynecological Endocrinology · doi:10.3109/09513599709152546 · Cited by 22 · see citing works
Clinical Evaluation of a New High-Flux Cellulose Acetate Membrane
Schaefer, R. M., Huber, L., Gilge, U., et al. (1989) · The International Journal of Artificial Organs · doi:10.1177/039139888901200204 · Cited by 22 · see citing works
Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline
Biagetti, B., Sarria‐Estrada, S., Ng-Wong, Y. K., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0561 · Cited by 22 · see citing works
Osorio, R. C., Pereira, M. P., Oh, T., et al. (2022) · Journal of neurosurgery · doi:10.3171/2022.8.jns221890 · Cited by 22 · see citing works
Alkabbani, A. G., Mon, S. Y., Hatipoğlu, B., Kennedy, L., Faiman, C., Weil, R. J., & Hamrahian, A. H. (2013) · Pituitary · doi:10.1007/s11102-013-0473-5 · Cited by 21 · see citing works
Bashari, W. A., van der Meulen, M., MacFarlane, J., Gillett, D., Senanayake, R., Serban, L., Powlson, A., Brooke, A. M., Scoffings, D. J., Jones, J., et al. (2022) · Pituitary · doi:10.1007/s11102-022-01229-9 · Cited by 21 · see citing works
Self-citationPredicting hypogonadotropic hypogonadism persistence in male macroprolactinoma
Rudman, Y., Duskin‐Bitan, H., Masri‐Iraqi, H., Akirov, A., & Shimon, I. (2022) · Pituitary · doi:10.1007/s11102-022-01259-3 · Cited by 21 · see citing works
Self-citationHow to manage intolerance to dopamine agonist in patients with prolactinoma
Stumpf, M. A. M., Pinheiro, F. M. M., da Silva, G. O., Cescato, V. Â. S., Musolino, N. R. D. C., Cunha-Neto, M. B. C., & Glezer, A. (2023) · Pituitary · doi:10.1007/s11102-023-01313-8 · Cited by 21 · see citing works
Mennella, J. A., & Pepino, M. Y. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.03.006 · Cited by 20 · see citing works
Role of Cannulated Prolactin Test in Evaluation of Hyperprolactinemia - A Retrospective Study
Tsur, A., Dreyfuss, E., Ness-Abramof, R., Pollack, R. M., & Cahn, A. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0260 · Cited by 19 · see citing works
Besag, F., Vasey, M. J., & Salim, I. (2021) · CNS Drugs · doi:10.1007/s40263-021-00812-1 · Cited by 19 · see citing works
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature
Kuhn, E., Weinreich, A. A., Biermasz, N. R., Jørgensen, J. O. L., & Chanson, P. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0145 · Cited by 19 · see citing works
Self-citationSteeds, R. P., Stiles, C. E., Sharma, V., et al. (2019) · Echo Research and Practice · doi:10.1530/erp-18-0069 · Cited by 18 · see citing works
Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas
Indirli, R., Ferrante, E., Sala, E., Giavoli, C., Mantovani, G., & Arosio, M. (2019) · Hormones and Cancer · doi:10.1007/s12672-019-00363-4 · Cited by 18 · see citing works
Hypeprolactinemia: still an insidious diagnosis
Aliberti, L. M., Gagliardi, I., Dorizzi, R. M., Pizzicotti, S., Bondanelli, M., Zatelli, M. C., & Ambrosio, M. R. (2020) · Endocrine · doi:10.1007/s12020-020-02497-w · Cited by 18 · see citing works
Alexopoulou, O., Everard, V., Etoga, M. C. E., Fomekong, E., Gaillard, S., Parker, F., Raftopoulos, C., Chanson, P., & Maiter, D. M. (2021) · Endocrine · doi:10.1007/s12020-021-02701-5 · Cited by 18 · see citing works
Self-citationSurgery and Medical Treatment in Microprolactinoma: A Systematic Review and Meta-Analysis
Lu, J., Cai, L., Wu, Z., Lin, W., Xu, J., Zhu, Z., Wang, C., Li, Q., & Su, Z. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9930059 · Cited by 18 · see citing works
Hyperprolactinemia in postmenopausal women
Maor, ., & Berezin, M. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81368-4 · Cited by 17 · see citing works
Raven, L. M., Guttman-Jones, M., & Muir, C. A. (2021) · Endocrine · doi:10.1007/s12020-020-02563-3 · Cited by 15 · see citing works
Self-citationLombardi, M., Lupi, I., Cosottini, M., et al. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1389925 · Cited by 14 · see citing works
Zhong, H. P., Tang, H., Zhang, Y., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02054-0 · Cited by 14 · see citing works
Allard, L., Albarel, F., Bertherat, J. Y., Caron, P. J., Cortet, C., Courtillot, C., Delemer, B., Jublanc, C., Maiter, D. M., Nunes, M. L., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0125 · Cited by 14 · see citing works
Self-citationTargeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomas
Petersenn, S., & Heaney, A. P. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09554-9 · Cited by 13 · see citing works
Self-citationTreatments of psychiatric disorders, hyperprolactinemia and dopamine agonists
Chanson, P. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101711 · Cited by 13 · see citing works
Self-citationThe Role of Aromatase Inhibitors in Male Prolactinoma
Akirov, A., & Rudman, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041437 · Cited by 13 · see citing works
RODRIÍGUEZ-PUYOL, D., Martin-Oar, J. E., Cachofeiro, V., et al. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-2-352 · Cited by 12 · see citing works
Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertile
Drincic, A., Arseven, O. K., Sosa, E., Mercado, M., Kopp, P., & Molitch, M. E. (2003) · Pituitary · doi:10.1023/a:1026232124988 · Cited by 11 · see citing works
Self-citationPituitary tumour apoplexy within prolactinomas in children: a more aggressive condition?
Culpin, E., Crank, M., Igra, M. S., et al. (2018) · Pituitary · doi:10.1007/s11102-018-0900-8 · Cited by 11 · see citing works
Bazuhair, T., Aleid, B., & Almalki, M. (2023) · Cureus · doi:10.7759/cureus.35171 · Cited by 10 · see citing works
Coté, D. J., Kilgallon, J. L., Nawabi, N. L. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab868 · Cited by 9 · see citing works
Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapy
Brichta, C., Wurm, M., Krebs, A., Schwab, K. O., & van der Werf-Grohmann, N. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0475 · Cited by 6 · see citing works
Sousa, S. M. C. D., Meyer, E. J., Rankin, W. A., et al. (2017) · Pituitary · doi:10.1007/s11102-017-0833-7 · Cited by 5 · see citing works
Speed of response to dopaminergic agents in prolactinomas
Hage, C., & Salvatori, R. (2021) · Endocrine · doi:10.1007/s12020-021-02953-1 · Cited by 3 · see citing works
Self-citationHinojosa‐Amaya, J. M., Varlamov, E. V., McCartney, S., & Fleseriu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819949-7.00013-5 · Cited by 2 · see citing works
Self-citationChildhood‐onset prolactinomas—Should earlier surgery be considered?
McCormack, A. I. (2021) · Clinical Endocrinology · doi:10.1111/cen.14477 · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [38]38. Kaiser, U. & Ho, K. Pituitary physiology and diagnostic evaluation. In Williams Textbook of Endocrinology (eds Melmed, S., Koenig, R., Rosen, C. J., Auchus, R. J. & Goldfine, A, B.) 184-235 (Elsevier, 2019).
Cited by
Sorted by citations
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14 · see citing works
Self-citation
- Authors
- Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., Greenman, Y., Gurnell, M., Ho, K. K. Y., Honegger, J., Ioachimescu, A. G., Kaiser, U. B., Karavitaki, N., Katznelson, L., Lodish, M., Maiter, D., Marcus, H. J., McCormack, A., Molitch, M., Muir, C. A., Neggers, S., Pereira, A. M., Pivonello, R., Post, K., Raverot, G., Salvatori, R., Samson, S. L., Shimon, I., Spencer-Segal, J., Vila, G., Wass, J., & Melmed, S.
- Affiliations
- University of Duisburg-Essen (DE)
- Oregon Health & Science University (US)
- Universidade de Santiago de Compostela (ES)
- Vita-Salute San Raffaele University (IT)
- Leiden University Medical Center (NL)
- Massachusetts General Hospital (US)
- Universidade de São Paulo (BR)
- Université Paris-Saclay (FR)
- Kobe University Hospital (JP)
- Tel Aviv University (IL)
- University of Cambridge (GB)
- Garvan Institute of Medical Research (AU)
- University of Tübingen (DE)
- Medical College of Wisconsin (US)
- Brigham and Women's Hospital (US)
- University of Birmingham (GB)
- Stanford Medicine (US)
- University of California, San Francisco (US)
- Cliniques Universitaires Saint-Luc (BE)
- University College London Hospitals NHS Foundation Trust (GB)
- Northwestern University (US)
- St Vincent's Hospital Sydney (AU)
- Erasmus MC (NL)
- Amsterdam University Medical Centers (NL)
- University of Naples Federico II (IT)
- Mount Sinai Health System (US)
- Johns Hopkins University (US)
- Mayo Clinic in Florida (US)
- University of Michigan (US)
- Medical University of Vienna (AT)
- Churchill Hospital (GB)
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Petersenn, Stephan
- ORCID
- Petersenn, Stephan
- Fleseriu, Maria
- Casanueva, Felipe F.
- Giustina, Andrea
- Biermasz, Nienke
- Biller, Beverly M. K.
- Bronstein, Marcello
- Chanson, Philippe
- Fukuoka, Hidenori
- Greenman, Yona
- Gurnell, Mark
- Ho, Ken K. Y.
- Honegger, Jürgen
- Ioachimescu, Adriana G.
- Kaiser, Ursula B.
- Karavitaki, Niki
- Katznelson, Laurence
- Lodish, Maya
- Maiter, Dominique
- Marcus, Hani J.
- McCormack, Ann
- Molitch, Mark
- Muir, Christopher A.
- Neggers, Sebastian
- Pereira, Alberto M.
- Pivonello, Rosario
- Post, Kalmon
- Raverot, Gerald
- Salvatori, Roberto
- Samson, Susan L.
- Shimon, Ilan
- Spencer-Segal, Joanna
- Vila, Greisa
- Wass, John
- Melmed, Shlomo
- Venue
- Nature Reviews Endocrinology
- Published
- 2023-09-05
- Volume
- 19
- Issue
- 12
- Pages
- 722-740
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W4386449135
- Semantic Scholar
- b67e03e1f2c63652958e8d36ec35c8a16d8d2fe0
- Cited by
- 411
- References
- 193
- Citations by year
- 2026: 145 · 2025: 137 · 2024: 119 · 2023: 8
- FWCI
- 14.68
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-10-17)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Funders
- Cedars-Sinai Medical Center
- University College London Hospitals NHS Foundation Trust
- Wellcome / EPSRC Centre for Interventional and Surgical Sciences
- Engineering and Physical Sciences Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- prolactinoma, prolactin-secreting pituitary adenoma, hyperprolactinemia, dopamine agonist therapy, surgical treatment, radiotherapy, giant prolactinoma, treatment resistance, pituitary imaging
- MeSH terms
- Adolescent, Child, Diagnostic Imaging, Female, Humans, Hyperprolactinemia, Pituitary Neoplasms, Pregnancy, Prolactin, Prolactinoma, Dopamine Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
